Gafni, A.; Walter, S. D.; Birch, S.; Sendi, P. - In: Health Economics 17 (2008) 1, pp. 99-107
The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost-effectiveness analysis is the incremental cost-effectiveness ratio (ICER), which is compared with a threshold value...